Real-world treatment patterns, survival outcomes, and health care resource utilization (HCRU) for locally advanced or metastatic urothelial carcinoma (la/mUC) in Spain.

被引：0
|
作者：
Puente, Javier
Pinto, Alvaro
Vidal, Maria Jose Mendez
del Muro, Xavier Garcia
Maroto-Rey, Pablo
Vazquez-Estevez, Sergio
Luque, Raquel
Anido, Urbano
Strunz-McKendry, Torsten
Upadhyay, Anil
Montes, Jose
Nunez, Aurora Ortiz
Portela, Judit Gonzalez
Castellano, Daniel
机构：
[1] CIBERONC, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Hosp Clin San Carlos, Med Oncol Dept, Madrid, Spain
[2] Hosp Univ La Paz, Serv Oncol, Madrid, Spain
[3] Hosp Univ Reina Sofia, Med Oncol Dept, Maimonides Inst Biomed Res Cordoba IMIBIC, Cordoba, Spain
[4] Inst Catala Oncol, Barcelona, Spain
[5] Hosp Santa Creu & Sant Pau, Serv Oncol Med, Barcelona, Spain
[6] Hosp Univ Lucus Augusti, Serv Oncol Med, Lugo, Spain
[7] Hosp Univ Virgen Nieves, Granada, Spain
[8] Inst Invest Biosanitaria IBS, Granada, Spain
[9] Hosp Univ Santiago, Serv Oncol Med, Santiago, Spain
[10] Astellas Pharma Europe Ltd, Addlestone, Surrey, England
[11] Effice Res, Madrid, Spain
[12] Hosp Univ 12 Octubre, Serv Oncol Med, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
463
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-world treatment and quality of life (QOL) in locally advanced or metastatic urothelial carcinoma (la/mUC) in Saudi Arabia, Singapore, South Korea, Taiwan, and Turkey.
    Cheng, Li-Jen
    Kim, Janet
    Mukherjee, Apurba
    Milloy, Neil
    Unsworth, Mia
    Ng, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [22] Real-world use, dose intensity, and adherence to enfortumab vedotin (EV) in locally advanced or metastatic urothelial cancer (la/mUC)
    Tsingas, Konstantinos
    Parikh, Ravi Bharat
    Elsouda, Dina
    Mucha, Lisa
    Fuldeore, Rupali
    Hubbard, Rebecca A.
    Mamtani, Ronac
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] Real-world (rw) treatment patterns, sequencing, and outcomes in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) receiving avelumab first-line maintenance (1LM) in the US.
    Moon, Helen H.
    Kearney, Mairead
    Mahmoudpour, Seyed Hamidreza
    Ike, Chiemeka
    Morris, Valerie A.
    Rava, Andrew
    Kim, Sonia
    Sun, Haiyan
    Boyd, Marley
    Rey, Gabriel Gomez
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 605 - 605
  • [24] Real-world treatment patterns and clinical outcomes among patients with metastatic urothelial carcinoma.
    Geynisman, Daniel M.
    Broughton, Edward
    Alhasani, Hasan
    Hao, Yi
    Zhang, Ying
    Stwalley, Brian
    Le, Trong Kim
    Huo, Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis
    Niegisch, Guenter
    Grimm, Marc-Oliver
    Hardtstock, Fraence
    Krieger, Julia
    Starry, Alexandra
    Osowski, Ulrike
    Guenther, Silke
    Deiters, Barthold
    Maywald, Ulf
    Wilke, Thomas
    Kearney, Mairead
    FUTURE ONCOLOGY, 2024, 20 (19) : 1351 - 1366
  • [26] Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility
    Morgans, Alicia K.
    Galsky, Matthew D.
    Wright, Phoebe
    Hepp, Zsolt
    Chang, Nancy
    Willmon, Candice L.
    Sesterhenn, Steve
    Liu, Yutong
    Sonpavde, Guru P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (08) : 357e11 - 357e21
  • [27] Real-world survival and economic burden among patients with locally advanced or metastatic urothelial carcinoma in the United States
    Chen, Ronald C.
    Fuldeore, Rupali
    Greatsinger, Alexandra
    Hepp, Zsolt
    Liu, Qing
    Wright, Phoebe
    Xie, Bin
    Yang, Hongbo
    Young, Christopher
    Zhang, Adina
    Mucha, Lisa
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03) : 189e9 - 189e18
  • [28] Epidemiology, resource use, and treatment patterns of locally advanced or metastatic urothelial carcinoma in France
    Joly, Florence
    Culine, Stephane
    Roupret, Morgan
    Tricotel, Aurore
    Casarotto, Emilie
    Brice, Sandrine
    Minacori, Rafael
    Vuillet, Marthe
    Thomas, Marie-Catherine
    Leyland, Kirsten
    Upadhyay, Anil
    Munro, Vicki
    Strunz-McKendry, Torsten
    FUTURE ONCOLOGY, 2025, 21 (06) : 665 - 679
  • [29] Retrospective database analysis of real-world treatment patterns and sequencing in locally advanced or metastatic urothelial carcinoma patients receiving sacituzumab govitecan
    Mamtani, R.
    Katz, J.
    An, R.
    Boateng, F.
    Ghazi, Y.
    Brockman, M.
    Sierecki, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S1148 - S1149
  • [30] Real-World Treatment Patterns, Sequencing, and Outcomes in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Receiving Avelumab First-Line Maintenance in the United States
    Moon, Helen H.
    Kearney, Mairead
    Mahmoudpour, Seyed Hamidreza
    Ike, Chiemeka
    Morris, Valerie
    Rava, Andrew
    Kim, Sonia
    Sun, Haiyan
    Boyd, Marley
    Gomez Rey, Gabriel
    CURRENT ONCOLOGY, 2024, 31 (09) : 5662 - 5676
12345